Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying THL Credit, Inc. (TCRD)

Page 1 of 2

THL Credit, Inc. (NASDAQ:TCRD) investors should be aware of an increase in hedge fund sentiment of late.

In the 21st century investor’s toolkit, there are many gauges market participants can use to track stocks. A pair of the most useful are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top money managers can outperform their index-focused peers by a very impressive amount (see just how much).

Equally as integral, positive insider trading activity is another way to break down the financial markets. As the old adage goes: there are lots of motivations for an upper level exec to cut shares of his or her company, but only one, very clear reason why they would behave bullishly. Several empirical studies have demonstrated the valuable potential of this tactic if piggybackers understand what to do (learn more here).

With these “truths” under our belt, let’s take a peek at the key action regarding THL Credit, Inc. (NASDAQ:TCRD).

What have hedge funds been doing with THL Credit, Inc. (NASDAQ:TCRD)?

In preparation for this quarter, a total of 10 of the hedge funds we track were long in this stock, a change of 11% from the first quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their stakes considerably.

THL Credit, Inc. (NASDAQ:TCRD)According to our comprehensive database, Leon Cooperman’s Omega Advisors had the most valuable position in THL Credit, Inc. (NASDAQ:TCRD), worth close to $18.4 million, accounting for 0.3% of its total 13F portfolio. Sitting at the No. 2 spot is Silver Capital Management LLC, managed by Bruce Silver, which held a $4.2 million position; 4.3% of its 13F portfolio is allocated to the company. Other hedge funds that are bullish include Charles Clough’s Clough Capital Partners, Robert B. Gillam’s McKinley Capital Management and Israel Englander’s Millennium Management.

As one would reasonably expect, key money managers have jumped into THL Credit, Inc. (NASDAQ:TCRD) headfirst. Citadel Investment Group, managed by Ken Griffin, established the most valuable position in THL Credit, Inc. (NASDAQ:TCRD). Citadel Investment Group had 0.2 million invested in the company at the end of the quarter. Cliff Asness’s AQR Capital Management also made a $0.2 million investment in the stock during the quarter.

What do corporate executives and insiders think about THL Credit, Inc. (NASDAQ:TCRD)?

Bullish insider trading is most useful when the company in question has experienced transactions within the past half-year. Over the latest half-year time frame, THL Credit, Inc. (NASDAQ:TCRD) has seen 5 unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to THL Credit, Inc. (NASDAQ:TCRD). These stocks are Capital Southwest Corporation (NASDAQ:CSWC), Westwood Holdings Group, Inc. (NYSE:WHG), Pzena Investment Management, Inc. (NYSE:PZN), PennantPark Investment Corp. (NASDAQ:PNNT), and Noah Holdings Limited (ADR) (NYSE:NOAH). This group of stocks belong to the asset management industry and their market caps are closest to TCRD’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!